-
COVID-19 (CORONA VIRUS) AND LUNG CANCER
What is COVID-19? COVID-19 is an illness caused by a novel (new) coronavirus that was identified in December 2019. On March 11, 2020, the World…
-
LUCE WEBINAR ON THE ROLE OF THE EUROPEAN MEDICINES AGENCY
In depth webinar held on 26th of February 2020 with Kate Morgan, from Myeloma Patients Europe about the role of the European Medicines Agency (EMA) and…
-
LUNG CANCER EUROPE: 2020 POSITION PAPER. DISPARITIES AND CHALLENGES IN ACCESS TO LUNG CANCER DIAGNOSIS AND TREATMENT ACROSS EUROPE
Lung cancer is responsible for nearly 1 in 5 cancer related deaths in Europe, yet it remains a cancer that is underfunded and underrepresented. Previous…
-
LUCE WEBINARS
We have published two webinars from the autumn of 2019 that might be of interest, Lung cancer screening – Basic concepts and implementation, and Diagnosis and treatment…
-
LIVING WITH ALK+ LUNG CANCER
Lung cancer is a complex disease that can have various causes. In this booklet, you will find a lot of information if you or someone…
-
WELCOME TO THE 4TH EDITION OF THE LUCE REPORT
This report is an annual initiative led by lung cancer patient organisations, with the purpose of raising awareness about the biggest challenges that patients across…
-
2019 LUCE REPORT: EARLY DIAGNOSIS AND SCREENING
We are delighted to present LuCE’s 4th report on “Early Diagnosis and Screening”, at the European Parliament in Brussels on November 6th, in collaboration with…
-
LUCE’S FIRST CAPACITY BUILDING PROGRAM KICKS OFF!
A comprehensive training course aiming to empower a selected group of advocates with the knowledge and skills needed to take part in relevant decision making…
-
SURVEY FOR ALL LUNG CANCER PATIENTS!
“Lung cancer early diagnosis and screening challenges”. The results of the survey will be presented at the European Parliament in November, during Lung Cancer Awareness…
Keep Up-to-Date
Find out more about the latest news and events from Lung Cancer Europe.
